Who is sponsoring NCT04288297?

NCT04288297 is sponsored by Dr.Gerhard Kaufmann.

What drugs are being tested in NCT04288297?

Interventions in NCT04288297: distal minimally invasive chevron osteotomy.

What condition does NCT04288297 study?

NCT04288297 studies Hallux Valgus and Bunion.

Is NCT04288297 still recruiting?

NCT04288297 is currently completed. Last updated 2 March 2020.

Last reviewed 2020-03-02 · How we verify

NCT04288297

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Minimally Invasive Distal Chevron in Comparison to the Reverdin-Isham Osteotomy for Hallux Valgus Correction

Completed Last updated 2 March 2020

What this trial tests

trial testing distal minimally invasive chevron osteotomy in Hallux Valgus and Bunion in 50 participants. Completed in 31 August 2019.

Timeline

1 December 2018

Primary endpoint
31 August 2019

31 August 2019

Quick facts

Lead sponsor	Dr.Gerhard Kaufmann
Status	Completed
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 December 2018
Primary completion	31 August 2019
Estimated completion	31 August 2019
Sites	1 location across Austria

Drugs / interventions tested

distal minimally invasive chevron osteotomy

Conditions studied

Hallux Valgus and Bunion — all drugs for Hallux Valgus and Bunion →

Sponsor

Dr.Gerhard Kaufmann

Who can join

18 and older, any sex, with Hallux Valgus and Bunion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study analyses the Reverdin Isham procedure, which is the most popular minimally invasive surgical hallux valgus correction method and the minimally invasive chevron osteotomy, representing the standard technique of open surgery. It is hypothesized that the two techniques would show significant differences in regard to radiological outcome (Hypothesis 1), clinical outcome (Hypothesis 2) and development of radiological recurrence (Hypothesis 3).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Midterm Results Following Minimally Invasive Distal Chevron Osteotomy: Comparison With the Minimally Invasive Reverdin-Isham Osteotomy by Means of Meta-analysis.
Kaufmann G, Weiskopf D, Liebensteiner M, Ulmer H, et al · · 2021 · cited 9× · PMID 34182496 · DOI 10.21873/invivo.12490

Verify or expand the search:

Other Dr.Gerhard Kaufmann trials

Trials by the same sponsor.

NCT04823884 — Short-term Results After Minimally Invasive Chevron Osteotomy for Hallux Valgus Correction · NA · completed
NCT04284618 — Off Axis View Radiographs Assessing Hallux Valgus Interphalangeus in Hallux Valgus Deformity · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04288297 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr.Gerhard Kaufmann
Last refreshed: 2 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04288297.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing